![Full Text of PDF](img/ico_pdf_full.gif)
Article in Japanese
Pulmonary tumor thrombotic microangiopathy responding to chemotherapy
Takashi Ishiguro1) Noboru Takayanagi1) Masashi Ando2) Tsutomu Yanagisawa1) Yoshihiko Shimizu3) Yutaka Sugita1)
1)Department of Respiratory Medicine, Saitama Cardiovascular and Respiratory Center 2)Breast and Oncology Division, National Cancer Center Hospital 3)Department of Pathological Diagnosis, Saitama Cardiovascular and Respiratory Center
A 65-year-old man without a history of cancer presented to our hospital because he was suspected of having acute pulmonary thromboembolism. Dyspnea that had developed 1 month before admission, had worsened 1-week before admission. Chest computed tomography showed faint ground-glass opacities in the lung fields without filling defects in the pulmonary arteries. He was transferred to the department of respiratory medicine for further investigation. Perfusion scintigraphy showed multiple, small perfusion defects throughout both lungs, and laboratory data showed increased lactic dehydrogenase value and thrombocytopenia. We suspected intravascular lymphoma, and a bone marrow aspiration smear detected malignant cells. We started chemotherapy on a diagnosis of intravascular lymphoma, which resulted in remarkable improvement of respiratory failure and pulmonary hypertension. After that, further evaluation of bone marrow specimen with immunostaining, the malignant cells were found not to be lymphoma cells but cancer cells. The primary site of the cells was not found by further investigation. Because of improvement of oxygenation and pulmonary hypertension, we performed transbronchial lung biopsy and diagnosed pulmonary tumor thrombotic microangiopathy. Here, we report this case and review previous reports.
Pulmonary tumor thrombotic microangiopathy Pulmonary hypertension Carcinoma of unknown primary site Pulmonary tumor embolism PTTM
Received 平成23年2月15日
JJRS, 49(9): 681-687, 2011